BCL-2 OVEREXPRESSION IN BASALOID PROLIFERATIONS OVERLYING DERMATOFIBROMAS AND BASAL-CELL CARCINOMAS

Citation
K. Rossen et al., BCL-2 OVEREXPRESSION IN BASALOID PROLIFERATIONS OVERLYING DERMATOFIBROMAS AND BASAL-CELL CARCINOMAS, APMIS. Acta pathologica, microbiologica et immunologica Scandinavica, 105(1), 1997, pp. 35-40
Citations number
26
Categorie Soggetti
Pathology,Microbiology,Immunology
ISSN journal
09034641
Volume
105
Issue
1
Year of publication
1997
Pages
35 - 40
Database
ISI
SICI code
0903-4641(1997)105:1<35:BOIBPO>2.0.ZU;2-3
Abstract
Basaloid proliferations overlying dermatofibromas resembling superfici al basal cell carcinomas have been interpreted both as reactive/regres sive and frankly malignant. Basal cell carcinoma is a slow-growing tum our, which so far has been regarded as an actively proliferating lesio n with a high apoptotic activity. We examined immunohistochemically 6 dermatofibromas with overlying simple hyperplasia, 12 dermatofibromas with overlying basaloid proliferations, and 24 basal cell carcinomas f or expression of Ki-67 protein and bcl-2 protein. The Ki-67 labelling index represents an estimate of proliferative activity. Eel-2 protein suppresses apoptosis. The Ki-67 labelling indexes of basaloid prolifer ations, basal cell carcinomas, and normal epidermis were similar (11-1 5%, p<0.05, Mann-Whitney test). Eel-2 protein was expressed in all cel ls of basaloid proliferations, similar to the expression pattern in ba sal cell carcinomas. We suggest that basaloid proliferations overlying dermatofibromas might have achieved a phenotype that equals an early stage of BCC carcinogenesis.